Meeting
2012 ASCO Annual Meeting
Integrated next-generation sequencing and patient-derived xenografts to personalized cancer treatment.
Authors
Elena Garralda
Clinical Research Programme. Spanish National Cancer Research Center (CNIO), Madrid, Spain
Elena Garralda , Antonio Calles , Fernando López-Ríos , Siân Jones , Lisa M. Kann , Samuel V. Angiuoli , Luis A. Diaz, Jr. , Victor E. Velculescu , Pedro P. López-Casas , Francesca Sarno , Raquel Martinez , Carlos Gomez-Martin , Esther Conde , Cristobal Belda-Iniesta , Alfonso Valencia , Manuel Hidalgo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Experimental Therapeutics
Track
Developmental Therapeutics
Sub Track
New Targets, New Technologies
Citation
J Clin Oncol 30, 2012 (suppl; abstr 3068)
DOI
10.1200/jco.2012.30.15_suppl.3068
Abstract #
3068
Poster Bd #
16B
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2023 ASCO Annual Meeting
Genomic characterization of somatic mutations by race and ethnicity in pancreatic cancer defined through AACR project GENIE.
First Author: J. Alberto Maldonado
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA-based genomic landscape of early-onset pancreatic cancer.
First Author: Reagan Barnett